Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108658784A reveals a novel synthesis route for glaucoma drug intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103562196A reveals a novel reductive amination route for Dronedarone intermediates, offering high purity and scalable API manufacturing solutions.
Novel NaBH4/TFA reduction route improves yield to 80% and purity, offering significant cost reduction in API manufacturing.
Advanced synthesis of 2,4-dichloro-5-fluorobenzoyl chloride via dimer recycling. Enhances yield and reduces waste for reliable pharmaceutical intermediate supply chains.
Patent CN112300061B details a novel Ru-catalyzed C-H acylation method using amides, offering a cost-effective and scalable route for high-purity pharmaceutical intermediates.
Patent CN118290361B details a one-pot method for high-purity phenothiazine derivatives offering reduced waste and improved yield for pharmaceutical intermediate manufacturing supply chains.
Novel process using tri-n-propylamine improves yield and safety for ciprofloxacin intermediates. Cost-effective and scalable manufacturing solution.
Patent CN103275021B reveals mild acylation for high-purity intermediates. Enables cost reduction in agrochemical manufacturing and reliable supply chain continuity.
Patent CN113336715B reveals a green Lewis acid route for triazole fungicides, offering high purity and significant cost reduction in agrochemical intermediate manufacturing.
High-yield one-step Friedel-Crafts acylation method for pharmaceutical intermediates. Reduces corrosion and improves supply chain reliability significantly.
Patent CN108358871B reveals a high-yield synthesis for Photoinitiator 369 intermediates, offering significant cost reduction and safer manufacturing conditions for UV curing materials.
Patent CN102558105A discloses a novel semi-synthetic route for taxol analogs using abundant 1-dehydroxybaccatin VI. This method improves solubility and reduces multidrug resistance.
Patent CN1219531A enables high-yield hydroquinone diester production via simplified crystallization, offering significant cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN103242272A reveals a safer route avoiding phosgene and late-stage bromination, ensuring high purity and supply chain stability for gout medication manufacturers.
Patent CN1761644A details scalable synthesis of 4-amino-2-butenoyl chloride for kinase inhibitors. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN107474078B reveals a novel asymmetric thiacalix[4]arene synthesis integrating ferrocene and rhodamine B for dual-channel sensing applications.
Advanced Raney Nickel reduction process for high-purity iopromide intermediates. Cost-effective, atmospheric pressure synthesis suitable for commercial scale-up.
Novel acylation-first route for Ioxilan reduces impurities and enhances scalability for contrast agent manufacturing.
Patent CN113372187A details a mild 3-step route to BVPE using dual inhibitors, offering high purity and cost reduction for polymer manufacturers.
Discover the novel 3-step synthesis of BVPE from bibenzyl offering high purity and cost efficiency for polymer and electronic applications.